On The Improvement Of Drug GSP

Medicine shall not depend on oneself to the director,belongings,the Tang Dynasty,Sun Simiao "emergency prescriptions-big medicine sincere".Medicine,is the people's livelihood,the basic human rights protection in China,but the current health care system in our country has the interests of complicated and difficult to deal with,the reform changed repeatedly fail.In particular,the purchase and sale of drugs,the interests of various sectors staggered,unable to form a fair,honest,orderly,transparent,competitive drug market.But China is a country with a large population,with large base of the backward medical system bear too much pressure: whether the "medicine",the purchase and sale of medical institutions emerge in an endless stream of pharmaceutical commercial bribery cases,or the recent drug case: "Shandong vaccine case" and "Chongqing poison vaccine case",reflects the weakness of drug administration system in China,the patient pain in the "man-made",people heartache.Although our country in 2000,study medical system more developed western countries,has developed its own drugs GSP,(namely Good Supply Practice drug GSP for Pharmaceutical Products "acronym,in China for the" drug quality management standards ",hereinafter referred to as the drug GSP),has experienced four,but with little success.Compared with western countries,the drug is GSP drug market system established in the full competition,which requires a set of drugs to improve the management quality of the industry rule system constraints,and our country's medical system of medicine,most of the control at the hands of the state,although the state-owned pharmaceutical company supervision and sales of "a set of men,two the brand" has become the past,but in the drug market competition not sufficient under the GSP mode of drugs that do not copy the western,in line with China's national conditions,also broke the legal boundaries of domestic law,especially in China more than 90% prescription drugs and more than 60% of the non prescription drugs(OTC)are sold by hospitals and other medical institutions,medical institutions is one of the diagnosis and medicine,and the doctor has the rightprescription,patients trust and psychological attachment to the doctor based on the pharmaceutical wholesale and retail enterprises can not shake Moving medical institutions in the field of drug sales in the dominant position,the medical institutions have claimed that "only use,no sales" in China in order to raise medical ethics in the face of the model is not standing.Although the medical institution is managed by the health department,but such an important drug circulation sales,the 2015 edition of "drug quality management standards",the Ministry of health in 2012 to replace the version by the State Food and Drug Administration issued,no medical institutions should be included,so fantastic! This is in line with the circulation of drugs,sales,use of the real situation seriously out of touch.Xi Jinping said in a 2015 Fourth Plenary Session: "the rule of law reform should not rigidly adhere to the interests of the department." Current drug GSP and certification,if not from the legal level,the stripping sector interests,will not only increase the burden of drug companies,drug regulatory work can not get a good social effect.This is our "rule of law","economic development efforts in the direction of a serious departure from,so this will be the author and drug supervision work experience as the basis,legal problems exist,combing the existing GSP and certification of social problems,drug GSP certification issues,explore in real conditions,the legal framework and the improvement of GSP certification and make a contribution to the national medical law.